Novartis | NVS - Aset Lancar

Harga Saham
147.85
Perubahan Harian
4.86 3.40%
Bulanan
-3.20%
Tahunan
32.92%
Q2 Perkiraan
142.62




Aset Lancar Perubahan Tanggal
AbbVie USD 29.06B 523M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 29.61B 890M 2026-03
Bausch Health Companies USD 5.98B 179M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
J&J USD 59.17B 3.55B 2026-03
Merck USD 43.52B 4.04B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Zoetis USD 6.77B 185M 2025-12